New to site? Register


forgot password? X

Forgot Password


Fact sheet: Maviret (glecaprevir + pibrentasvir)

Fact sheet: Maviret (glecaprevir + pibrentasvir) Image

This fact sheet summarizes up-to-date information on Maviret. Maviret is a medication used to treat hepatitis C. It is approved in Canada for people with hepatitis C in the following situations:

  • those with any genotype of the virus who have never taken direct-acting antiretroviral (DAA) medication
  • those with any genotype of the virus who have taken DAA medication with a type of medicine called an NS5A inhibitor or an NS3/4A protease inhibitor (but not both types of medication) and who were not cured of the virus

Format : Fact sheet

Date of Publication : 2018 (revised in 2019)

Author : CATIE

Catalogue No. : ATI-50279

Availability : In Stock

Language : English

Download :  PDF


Related Resources

Browse By

Category Format Language Author